Physician profile
Cameron Blank
NPI 1467097188
$2,106.37
in general payments reported to CMS, 2019-2025
23 companies · $185 in 2025
The $185 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $553 · 2022: $528 · 2023: $434 · 2024: $406 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $870 · Education: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $870.11 |
| Education | $154.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $666.20 | 2022-2024 | Wakix |
| Jazz Pharmaceuticals INC. | $476.89 | 2021-2025 | |
| Lilly USA, LLC | $161.77 | 2021-2025 | Zepbound |
| Abbvie INC. | $151.73 | 2021 | |
| Zoll Respicardia, INC. | $146.06 | 2023-2025 | Remede System |
| Inspire Medical Systems, INC. | $123.95 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $56.43 | 2021 | |
| Azurity Pharmaceuticals, INC. | $38.83 | 2024 | Horizant |
| Fisher & Paykel Healthcare INC | $35.97 | 2024 | Fisher & Paykel Healthcare |
| Verona Pharma, INC. | $31.31 | 2025 | Ohtuvayre |
| Sk Life Science, INC. | $21.11 | 2021 | |
| Axsome Therapeutics, INC. | $21.09 | 2023 | Sunosi |
| Philips North America LLC | $20.10 | 2025 | Patient Interface Software |
| Supernus Pharmaceuticals, INC. | $18.66 | 2022 | |
| Mylan Specialty L.P. | $17.73 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $17.29 | 2022 | |
| Amneal Pharmaceuticals LLC | $16.54 | 2021 | |
| United Therapeutics Corporation | $16.53 | 2023 | Tyvaso |
| Livanova USA, INC. | $16.05 | 2021 | |
| Avadel Cns Pharmaceuticals, LLC | $15.61 | 2025 | Lumryz |
| Inogen, INC. | $12.93 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $12.00 | 2021 | |
| Neurocrine Biosciences, INC. | $11.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cameron Blank listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.